ArticleJournal of family medicine and primary care2019

A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus.

Tanya Tandon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.